Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The current state of the art for biological therapies and new small molecules in inflammatory bowel disease
Sudarshan Paramsothy, Adam Rosenstein, Saurabh Mehandru, et al.
Mucosal Immunology (2018) Vol. 11, Iss. 6, pp. 1558-1570
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Yi Rang Na, Michelle Stakenborg, Seung Hyeok Seok, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 9, pp. 531-543
Closed Access | Times Cited: 664
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sudarshan Paramsothy, Shaun Nielsen, Michael A. Kamm, et al.
Gastroenterology (2018) Vol. 156, Iss. 5, pp. 1440-1454.e2
Open Access | Times Cited: 405
Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6966-6966
Open Access | Times Cited: 76
IBD disease-modifying therapies: insights from emerging therapeutics
Niranjan G. Kotla, Yury Rochev
Trends in Molecular Medicine (2023) Vol. 29, Iss. 3, pp. 241-253
Closed Access | Times Cited: 62
Plasmonic Biosensors for Health Monitoring: Inflammation Biomarker Detection
Muhammad Amirul Islam, Jean‐François Masson
ACS Sensors (2025)
Closed Access | Times Cited: 2
Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification
Paulo Czarnewski, Sara Martina Parigi, Chiara Sorini, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 109
Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response
Jose U. Scher, Renuka R. Nayak, Carles Úbeda, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 5, pp. 282-292
Open Access | Times Cited: 96
Surgery in the age of biologics
Daniel J. Wong, Eve M. Roth, Joseph D. Feuerstein, et al.
Gastroenterology report (2019) Vol. 7, Iss. 2, pp. 77-90
Open Access | Times Cited: 79
Precision medicine in inflammatory bowel disease: concept, progress and challenges
Simon Borg‐Bartolo, Ray Boyapati, Jack Satsangi, et al.
F1000Research (2020) Vol. 9, pp. 54-54
Open Access | Times Cited: 78
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
John Gubatan, Kian Keyashian, Samuel J. S. Rubin, et al.
Clinical and Experimental Gastroenterology (2021) Vol. Volume 14, pp. 333-342
Open Access | Times Cited: 59
The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease
Shengjie Ma, Jiaxin Zhang, Heshi Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 51
Targeting cytokines in inflammatory bowel disease
Markus F. Neurath
Science Translational Medicine (2022) Vol. 14, Iss. 675
Closed Access | Times Cited: 39
SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of Inflammatory Bowel Diseases
Gabrielle Schanne, Amandine Vincent, Sylvie Miquel, et al.
Free Radical Research (2025), pp. 1-16
Closed Access | Times Cited: 1
Innovations in Oral Therapies for Inflammatory Bowel Disease
Christopher Ma, Robert Battat, Parambir S. Dulai, et al.
Drugs (2019) Vol. 79, Iss. 12, pp. 1321-1335
Closed Access | Times Cited: 65
Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases
Maria Barra, Tal Danino, Daniel Garrido
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 65
Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing
Gwo‐Tzer Ho, Jennifer A. Cartwright, Emily Thompson, et al.
Inflammatory Bowel Diseases (2020) Vol. 26, Iss. 8, pp. 1131-1143
Open Access | Times Cited: 60
Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study
George Khoudari, Emad Mansoor, Benjamin Click, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 20, Iss. 5, pp. e974-e983
Open Access | Times Cited: 54
Bifidobacterium longum Ameliorates Dextran Sulfate Sodium-Induced Colitis by Producing Conjugated Linoleic Acid, Protecting Intestinal Mechanical Barrier, Restoring Unbalanced Gut Microbiota, and Regulating the Toll-Like Receptor-4/Nuclear Factor-κB Signaling Pathway
Chen Yang, Haiqin Chen, Jiuhong Ding, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 48, pp. 14593-14608
Closed Access | Times Cited: 51
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Nurulamin M Noor, Paula Sousa, Stéphane Paul, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 8, pp. 1254-1264
Open Access | Times Cited: 44
Identification of a unique subset of tissue-resident memory CD4 + T cells in Crohn’s disease
Takehito Yokoi, Mari Murakami, Takako Kihara, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 34
Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease
Ayano Kondo, Siyuan Ma, Michelle Y. Y. Lee, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1940-1952
Open Access | Times Cited: 40
Walnut oil alleviates DSS–induced colitis in mice by inhibiting NLRP3 inflammasome activation and regulating gut microbiota
Fujun Miao, Chunlan Shan, Ting Ma, et al.
Microbial Pathogenesis (2021) Vol. 154, pp. 104866-104866
Closed Access | Times Cited: 39
A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation
Yue Wang, Ruiwei Ye, Liming Fan, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 92, pp. 117420-117420
Closed Access | Times Cited: 13
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities
Jiewen Wang, Guangbo Kang, Huiying Lu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 5
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases
Yi Li, Jianping Chen, Andrew A. Bolinger, et al.
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. Supplement_2, pp. S38-S62
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top